Commonwealth Numbered Regulations

1986 No. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 4

SCHEDULE 4
Regulation 6
AMENDMENTS OF SCHEDULE 5 TO THE PRINCIPAL REGULATIONS
1. Omit item 22, substitute the following items:

"22 (1) Bromocriptine Mesylate,
Capsules, 5 mg (base)

(2) Bromocriptine Mesylate,
          Capsules, 10 mg (base)             With the written authority of
the
Secretary-
Acromegaly, prior to surgery or
radiotherapy or where surgery or
radiotherapy is inappropriate
Parkinson's disease where
treatment with levodopa is
unsatisfactory
Pathological hyperprolactinaemia
where appropriate surgery or
radiotherapy is not indicated or
has already been used with
incomplete resolution
   22A    Bromocriptine Mesylate, Tablets,

          2.5 mg (base)                      Urgent suppression of
physiological
lactation
With the written authority of the
Secretary-
Acromegaly, prior to surgery or
radiotherapy or where surgery or
radiotherapy is inappropriate
Parkinson's disease where
treatment with levodopa is
unsatisfactory
Pathological hyperprolactinaemia
where appropriate surgery or
radiotherapy is not indicated or
has already been used with
incomplete resolution".
2. Omit item 35.
3. Omit item 40, substitute the following item:

"40 (1) Chloramphenicol Capsules, B.P. Bacterial meningitis

(2) Chloramphenicol Palmitate
          Mixture, B.P.                      Intracranial bacterial
infections
Intraocular infections
Rickettsioses

(3) Chloramphenicol Sodium
          Succinate, B.P.                    Typhoid

The treatment of other serious
infections in a patient where it is
established by appropriate
bacteriological testing that
chloramphenicol is the only
suitable antibiotic listed as a
pharmaceutical benefit for use in
treating the infection in the
patient".
4. Omit item 44, substitute the following item:
   "44   Cholestyramine                     Bile salt malabsorption
associated
with ileal resection or proven
ileal disease
Hypercholesterolaemia
Pruritis associated with partial
biliary obstruction not responding
to other therapy
Severe diarrhoea associated with
pelvic irradiation".
5. After item 47 insert the following item:
   "47A    Clomiphene Tablets, B.P.        With the written authority of the

Secretary-
Anovulatory infertility".
6. Omit item 50, substitute the following item:
   "50    Colestipol Hydrochloride         Hypercholesterolaemia".

7. Omit item 52.
8. After item 66 insert the following item:
   "67    Doxorubicin Hydrochloride        Acute leukaemia

Breast cancer
Endometrial carcinoma
Ewing's sarcoma
Gastric cancer
Hepatoma
Intravesicular use in bladder cancer
Lymphoma
Multiple myeloma
Neuroblastoma
Osteosarcoma
Ovarian cancer
Soft tissue sarcoma
Thyroid cancer
Wilms' tumour".
9. After item 92 insert the following item:
   "92A    Isotretinoin                    With the written authority of the

Secretary-
Severe cystic acne not responsive
to other therapy". 10. Omit item 95. 11. After item 101 insert the following
item:
   "101A   Mefenamic Acid Capsules, B.P.   Dysmenorrhoea

Menorrhagia". 12. Omit item 164, substitute the following item:
   "164    Tamoxifen Citrate Tablets, B.P. Recurrent or metastatic breast

cancer". 13. Omit item 173.